Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2003 Aug;58(8):686–689. doi: 10.1136/thorax.58.8.686

Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)

J Chan 1, C Ng 1, Y Chan 1, T Mok 1, S Lee 1, S Chu 1, W Law 1, M Lee 1, P Li 1
PMCID: PMC1746764  PMID: 12885985

Abstract

Background: Severe acute respiratory syndrome (SARS) was diagnosed in Hong Kong in over 1700 patients between March and early June 2003.

Methods: 115 patients diagnosed with SARS were admitted to Queen Elizabeth Hospital, a large regional hospital in Hong Kong, from March 2003, of whom 100 were either discharged or were dead at 31 May. The patients were prospectively studied after admission to assess their short term outcomes and the risk factors associated with adverse outcomes, defined as death or the need for mechanical ventilation

Results: At the time of writing 18 patients had died, with a crude mortality rate of 15.7% and a 21 day mortality of 10% (standard error 3%). Thirty nine patients (34%) were admitted to the intensive care unit, 30 of whom (26%) required mechanical ventilation. Multivariate analysis showed that age above 60 (hazards ratio (HR) 3.5, 95% CI 1.2 to 10.2; p=0.02), presence of diabetes mellitus or heart disease (HR 9.1, 95% CI 2.8 to 29.1; p<0.001), and the presence of other comorbid conditions (HR 5.2, 95% CI 1.4 to 19.7; p=0.01) were independently associated with mortality. However, only the presence of diabetes mellitus and/or cardiac disease (HR 7.3, 95% CI 3.1 to 17.4; p<0.001) was associated with adverse outcomes as a whole.

Conclusion: SARS is a new disease entity that carries significant morbidity and mortality. Specific clinical and laboratory parameters predicting unfavourable outcomes have been identified.

Full Text

The Full Text of this article is available as a PDF (116.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Booth Christopher M., Matukas Larissa M., Tomlinson George A., Rachlis Anita R., Rose David B., Dwosh Hy A., Walmsley Sharon L., Mazzulli Tony, Avendano Monica, Derkach Peter. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003 May 6;289(21):2801–2809. doi: 10.1001/jama.289.21.JOC30885. [DOI] [PubMed] [Google Scholar]
  2. Donnelly Christl A., Ghani Azra C., Leung Gabriel M., Hedley Anthony J., Fraser Christophe, Riley Steven, Abu-Raddad Laith J., Ho Lai-Ming, Thach Thuan-Quoc, Chau Patsy. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003 May 24;361(9371):1761–1766. doi: 10.1016/S0140-6736(03)13410-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Drosten Christian, Günther Stephan, Preiser Wolfgang, van der Werf Sylvie, Brodt Hans-Reinhard, Becker Stephan, Rabenau Holger, Panning Marcus, Kolesnikova Larissa, Fouchier Ron A. M. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003 Apr 10;348(20):1967–1976. doi: 10.1056/NEJMoa030747. [DOI] [PubMed] [Google Scholar]
  4. Fine M. J., Smith M. A., Carson C. A., Mutha S. S., Sankey S. S., Weissfeld L. A., Kapoor W. N. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996 Jan 10;275(2):134–141. [PubMed] [Google Scholar]
  5. Koren Gideon, King Susan, Knowles Sandra, Phillips Elizabeth. Ribavirin in the treatment of SARS: A new trick for an old drug? CMAJ. 2003 May 13;168(10):1289–1292. [PMC free article] [PubMed] [Google Scholar]
  6. Ksiazek Thomas G., Erdman Dean, Goldsmith Cynthia S., Zaki Sherif R., Peret Teresa, Emery Shannon, Tong Suxiang, Urbani Carlo, Comer James A., Lim Wilina. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003 Apr 10;348(20):1953–1966. doi: 10.1056/NEJMoa030781. [DOI] [PubMed] [Google Scholar]
  7. Lee Nelson, Hui David, Wu Alan, Chan Paul, Cameron Peter, Joynt Gavin M., Ahuja Anil, Yung Man Yee, Leung C. B., To K. F. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003 Apr 7;348(20):1986–1994. doi: 10.1056/NEJMoa030685. [DOI] [PubMed] [Google Scholar]
  8. Meduri G. U., Headley A. S., Golden E., Carson S. J., Umberger R. A., Kelso T., Tolley E. A. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998 Jul 8;280(2):159–165. doi: 10.1001/jama.280.2.159. [DOI] [PubMed] [Google Scholar]
  9. Niederman M. S., Mandell L. A., Anzueto A., Bass J. B., Broughton W. A., Campbell G. D., Dean N., File T., Fine M. J., Gross P. A. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001 Jun;163(7):1730–1754. doi: 10.1164/ajrccm.163.7.at1010. [DOI] [PubMed] [Google Scholar]
  10. Oba Yuji. The use of corticosteroids in SARS. N Engl J Med. 2003 May 15;348(20):2034–2035. doi: 10.1056/NEJM200305153482017. [DOI] [PubMed] [Google Scholar]
  11. Peiris J. S. M., Chu C. M., Cheng V. C. C., Chan K. S., Hung I. F. N., Poon L. L. M., Law K. I., Tang B. S. F., Hon T. Y. W., Chan C. S. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003 May 24;361(9371):1767–1772. doi: 10.1016/S0140-6736(03)13412-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Peiris J. S. M., Lai S. T., Poon L. L. M., Guan Y., Yam L. Y. C., Lim W., Nicholls J., Yee W. K. S., Yan W. W., Cheung M. T. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003 Apr 19;361(9366):1319–1325. doi: 10.1016/S0140-6736(03)13077-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rello J., Quintana E., Ausina V., Puzo C., Net A., Prats G. Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1320–1324. doi: 10.1164/ajrccm/142.6_Pt_1.1320. [DOI] [PubMed] [Google Scholar]
  14. So Loletta K-Y, Lau Arthur C. W., Yam Loretta Y. C., Cheung Thomas M. T., Poon Edwin, Yung Raymond W. H., Yuen K. Y. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet. 2003 May 10;361(9369):1615–1617. doi: 10.1016/S0140-6736(03)13265-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tsang Kenneth W., Ho Pak L., Ooi Gaik C., Yee Wilson K., Wang Teresa, Chan-Yeung Moira, Lam Wah K., Seto Wing H., Yam Loretta Y., Cheung Thomas M. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003 Mar 31;348(20):1977–1985. doi: 10.1056/NEJMoa030666. [DOI] [PubMed] [Google Scholar]
  16. van Woensel J. B. M., van Aalderen W. M. C., de Weerd W., Jansen N. J. G., van Gestel J. P. J., Markhorst D. G., van Vught A. J., Bos A. P., Kimpen J. L. L. Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax. 2003 May;58(5):383–387. doi: 10.1136/thorax.58.5.383. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES